Increased Drug Information Welcomed By Patient Organisation
Updated safety advice will boost informed patient choice, says Arthritis Care, welcoming the new instruction by the Medicines and Healthcare products Regulatory Authority (MHRA) for pharmaceutical manufacturers to update information on the risks and benefits of recently-reviewed drugs. The order from the government’s drug watchdog follows a European review of the safety of non-steroidal anti-inflammatory drugs (NSAIDs).
Read More